ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 76 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q1 2014. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2014 | $59,000 | – | 5,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,368,500 | $3,134,000 | 0.61% |
| TANG CAPITAL MANAGEMENT LLC | 365,000 | $836,000 | 0.46% |
| Abingworth LLP | 603,740 | $1,352,000 | 0.38% |
| Cheyne Capital Management (UK) LLP | 150,000 | $338,000 | 0.09% |
| Telemetry Investments, L.L.C. | 50,000 | $114,000 | 0.07% |
| Rotella Capital Management, Inc. | 19,473 | $45,000 | 0.04% |
| SABBY MANAGEMENT, LLC | 461,957 | $1,058,000 | 0.03% |
| Nine Chapters Capital Management LLC | 113,700 | $260,000 | 0.02% |
| STONERIDGE INVESTMENT PARTNERS LLC | 49,471 | $113,000 | 0.02% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 87,388 | $200,000 | 0.01% |